Virtual, Decentralized, Site-less Trials… What Does it All Mean?
March 12, 2020
Patient-facing digital technologies are playing an increasingly important role in clinical trials, to the point where including virtual components in trials has become mainstream. Join Kathy Vandebelt, Global Head of Clinical Innovation at Oracle Health Sciences to discuss where the industry stands on terms like "virtual" or "decentralized" trials, what are the benefits and challenges, and what does the future hold for all of us involved.
Live: Thursday, Mar. 12, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
On demand available after airing until Mar. 12, 2021.